The initial public offering (IPO) of Accretion Pharmaceuticals opened for subscription today, May 14, 2025. The SME public ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands ...

Verrica Pharmaceuticals, Inc. ( NASDAQ: VRCA) Q1 2025 Corporate Update Conference Call May 13, 2025 4:30 PM ET Kevin Gardner - Managing Director LifeSci Advisors Jayson Rieger - President and CEO John ...

GSK Pharma reported a 35% rise in net profit to Rs 263 crore in Q4 FY25, while Aditya Birla Capital reported a net profit of ...

UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced ...

If you told a private-equity suitor about a regulatory headache, but not shareholders, was the event disclosable or not? A 15 ...

Company reports $3.4 million in YCANTH revenue, reflective of increasing demand, following the dispensing of more than 10,000 applicator units in t ...

Q1 2025 Earnings Call Transcript May 7, 2025 Operator: Hello and welcome to Mirum Pharmaceuticals Reports First Quarter 2025 ...

China reportedly criticised the deal, saying it could be used to squeeze its products out of Britain’s supply chains.

UNLOXCYT (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma Special meeting of stockholders to vote on Merge ...

On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP) in ...

Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but it ...